LMR Partners LLP - CLOVIS ONCOLOGY INC ownership

Quarter-by-quarter ownership
LMR Partners LLP ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$9,612,000
-3.7%
13,099,0000.0%0.18%
+5.4%
Q2 2022$9,986,000
+20.8%
13,099,0000.0%0.17%
+75.0%
Q1 2022$8,268,000
-18.2%
13,099,0000.0%0.10%
-6.8%
Q4 2021$10,108,000
-14.1%
13,099,0000.0%0.10%
-22.6%
Q3 2021$11,770,000
-14.6%
13,099,0000.0%0.13%
-36.1%
Q2 2021$13,780,000
-7.3%
13,099,0000.0%0.21%
-43.8%
Q1 2021$14,861,000
+27.0%
13,099,0000.0%0.37%
+103.3%
Q4 2020$11,702,000
-8.5%
13,099,0000.0%0.18%
-30.8%
Q3 2020$12,793,00013,099,0000.26%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
HIGHBRIDGE CAPITAL MANAGEMENT LLC 64,842,000$63,520,0003.42%
QVT Financial LP 15,000,000$14,638,0001.79%
ARISTEIA CAPITAL, L.L.C. 22,150,000$21,214,0000.87%
WHITEBOX ADVISORS LLC 9,300,000$8,861,0000.37%
LMR Partners LLP 13,099,000$12,793,0000.26%
CAPSTONE INVESTMENT ADVISORS, LLC 6,100,000$5,842,0000.03%
WOLVERINE ASSET MANAGEMENT LLC 1,500,000$1,442,0000.01%
WELLS FARGO & COMPANY/MN 2,025,000$1,982,0000.00%
DEUTSCHE BANK AG\ 1,968,000$1,875,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CLOVIS ONCOLOGY INC shareholders